Celldex Therapeutics buy Wolfe Research
Start price
23.03.26
/
50%
€28.40
Target price
23.03.27
€38.10
Performance (%)
-9.68%
Price
10.06.26
€25.25
Summary
This prediction is currently active. With a performance of -9.68%, the BUY prediction by Wolfe_Research is trending in the wrong direction. This prediction currently runs until 23.03.27. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 3.061% | 3.061% |
| iShares Core DAX® | -2.796% | -1.396% |
| iShares Nasdaq 100 | -6.352% | -0.407% |
| iShares Nikkei 225® | -6.943% | -0.275% |
| iShares S&P 500 | -3.410% | 0.396% |
Comments by Wolfe_Research for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $44.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Wolfe_Research for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€29.60
25.09.24
25.09.24
€45.76
25.09.25
25.09.25
-27.70%
26.09.25
26.09.25
Celldex Therapeutics
Start price
Target price
Perf. (%)
€32.00
11.06.24
11.06.24
€47.50
11.06.25
11.06.25
-45.31%
12.06.25
12.06.25